scholarly journals Multiple bone metastases from an amelanotic melanoma of unknown primary origin

2019 ◽  
Vol 35 (2) ◽  
pp. 125-126
Author(s):  
Yeh Tang ◽  
Yue-Chiu Su
Keyword(s):  
Bone Metastases ◽  
Amelanotic Melanoma ◽  
Unknown Primary ◽  
Primary Origin ◽  
Multiple Bone Metastases ◽  
Unknown Primary Origin

scholarly journals Vemurafenib-associated neutrophilic panniculitis in a patient with metastatic amelanotic melanoma presenting as cancer of unknown primary origin

2016 ◽  
Vol 34 (2) ◽  
pp. 88-91 ◽  
Author(s):  
Yu-Ching Weng ◽  
Chien-Shan Chiu ◽  
Tseng-Hsi Lin ◽  
Jui-Lung Shen ◽  
Chii-Shuenn Yang ◽  
...  
Keyword(s):  
Amelanotic Melanoma ◽  
Cancer Of Unknown Primary ◽  
Unknown Primary ◽  
Primary Origin ◽  
Unknown Primary Origin

Current concepts in the diagnosis and management of neuroendocrine neoplasms of unknown primary origin

2020 ◽  
Vol 44 (4) ◽  
Author(s):  
Krystallenia I. Alexandraki ◽  
Marina Tsoli ◽  
Georgios Kyriakopoulos ◽  
Anna Angelousi ◽  
Georgios Nikolopoulos ◽  
...  
Keyword(s):  
Unknown Primary ◽  
Neuroendocrine Neoplasms ◽  
Diagnosis And Management ◽  
Primary Origin ◽  
Unknown Primary Origin

Adenocarcinoma of Unknown Primary Origin

1981 ◽  
Vol 71 (12) ◽  
pp. 1431-1434 ◽  
Author(s):  
S. RAJU INDUPALLI ◽  
AGOP Y. BEDIKIAN ◽  
GERALD P. BODEY
Keyword(s):  
Unknown Primary ◽  
Primary Origin ◽  
Unknown Primary Origin

scholarly journals Cervical Malignant Tumors of Unknown Primary Origin; From View of Roentgen Diagnosis.

1994 ◽  
Vol 87 (10) ◽  
pp. 1419-1426
Author(s):  
Katsuhiko FUKAMOTO ◽  
Masafumi NAKAGAWA ◽  
Naoyuki KONO
Keyword(s):  
Malignant Tumors ◽  
Unknown Primary ◽  
Roentgen Diagnosis ◽  
Primary Origin ◽  
Unknown Primary Origin

scholarly journals Expression of Glycolysis-Related Proteins in Cancer of Unknown Primary Origin

2021 ◽  
Vol 11 ◽  
Author(s):  
Murilo Bonatelli ◽  
Isabella Fernandes Fornari ◽  
Priscila Neves Bernécule ◽  
Lara Esquiapatti Pinheiro ◽  
Ricardo Filipe Alves Costa ◽  
...  
Keyword(s):  
Overall Survival ◽  
Lymph Nodes ◽  
Glucose Transporter ◽  
Metastatic Cancer ◽  
Multivariable Analysis ◽  
Cancer Of Unknown Primary ◽  
Unknown Primary ◽  
Primary Origin ◽  
Related Proteins ◽  
Unknown Primary Origin

IntroductionCancer of unknown primary origin (CUP) is defined as metastatic cancer without identification of the primary site. Considering that only 15–20% of patients with CUP show a favorable outcome, identifying biomarkers may help improve the clinical management of patients who do not respond well to conventional therapies. In this context, the study of the metabolic profile of CUP may pave the way to establish new biomarkers and/or therapeutic targets; therefore, this study aimed to characterize the expression of metabolism-related proteins in CUP.Materials and MethodsThe expression of monocarboxylate transporters MCT1, MCT2 and MCT4, their chaperone CD147, the glucose transporter GLUT1 and the pH regulator CAIX was evaluated by immunohistochemistry in a series of 118 CUP patients, and the results were associated with the available clinicopathological information.ResultsThe metabolism-related proteins MCT1, MCT4, CD147, GLUT1 and CAIX were expressed in a critical portion of the CUP (approximately 20 to 70%). MCT1 and CD147 were both more frequently expressed in cases with lymph nodes as metastasis dominant sites (p = 0.001) as well as in samples from lymph nodes (p <0.001 and p = 0.002, respectively), while MCT1 expression was more frequently expressed in squamous cell carcinomas (p = 0.045). A higher overall survival was observed in patients with tumors positive for GLUT1 and CAIX expression (p = 0.011 and p = 0.041, respectively), but none of the proteins was an independent prognostic factor for overall survival in multivariable analysis.ConclusionThe results suggest that a portion of CUPs present a hyperglycolytic phenotype, which is associated with higher overall survival.

Sign in / Sign up

Export Citation Format

Share Document